Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP498799.RA8Ts6VTqM1hDU28tQtWpqV5daGcFaxEuqYz4MRqUSSas130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP498799.RA8Ts6VTqM1hDU28tQtWpqV5daGcFaxEuqYz4MRqUSSas130_assertion type Assertion NP498799.RA8Ts6VTqM1hDU28tQtWpqV5daGcFaxEuqYz4MRqUSSas130_head.
- NP498799.RA8Ts6VTqM1hDU28tQtWpqV5daGcFaxEuqYz4MRqUSSas130_assertion description "[COX-2 expression in the undifferentiated carcinoma deserves special consideration due to its prognosis and to the fact that selective COX-2 inhibitors were found to enhance tumour response to radiation in some studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498799.RA8Ts6VTqM1hDU28tQtWpqV5daGcFaxEuqYz4MRqUSSas130_provenance.
- NP498799.RA8Ts6VTqM1hDU28tQtWpqV5daGcFaxEuqYz4MRqUSSas130_assertion evidence source_evidence_literature NP498799.RA8Ts6VTqM1hDU28tQtWpqV5daGcFaxEuqYz4MRqUSSas130_provenance.
- NP498799.RA8Ts6VTqM1hDU28tQtWpqV5daGcFaxEuqYz4MRqUSSas130_assertion SIO_000772 15947945 NP498799.RA8Ts6VTqM1hDU28tQtWpqV5daGcFaxEuqYz4MRqUSSas130_provenance.
- NP498799.RA8Ts6VTqM1hDU28tQtWpqV5daGcFaxEuqYz4MRqUSSas130_assertion wasDerivedFrom befree-2016 NP498799.RA8Ts6VTqM1hDU28tQtWpqV5daGcFaxEuqYz4MRqUSSas130_provenance.
- NP498799.RA8Ts6VTqM1hDU28tQtWpqV5daGcFaxEuqYz4MRqUSSas130_assertion wasGeneratedBy ECO_0000203 NP498799.RA8Ts6VTqM1hDU28tQtWpqV5daGcFaxEuqYz4MRqUSSas130_provenance.